Brochure | February 14, 2024

Next Innovative Therapeutics: Antibody Drug Conjugates

Samsung

As a trusted CDMO partner, Samsung Biologics is proud to expand its range of services to include the production of antibody drug conjugates (ADCs). Using our advanced scientific know-how, we’ve built a strong foundation to offer an innovative approach to therapeutic development.

Our parallel development service works seamlessly with our existing antibody capabilities, all under one roof, to ensure we meet the needs of our clients and help them reach the market faster.

access the Brochure!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

Samsung Biologics